ZA201104319B - Crystalline forms of a 3-carboxypropyl-aminotetralin compound - Google Patents

Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Info

Publication number
ZA201104319B
ZA201104319B ZA2011/04319A ZA201104319A ZA201104319B ZA 201104319 B ZA201104319 B ZA 201104319B ZA 2011/04319 A ZA2011/04319 A ZA 2011/04319A ZA 201104319 A ZA201104319 A ZA 201104319A ZA 201104319 B ZA201104319 B ZA 201104319B
Authority
ZA
South Africa
Prior art keywords
carboxypropyl
crystalline forms
aminotetralin compound
aminotetralin
compound
Prior art date
Application number
ZA2011/04319A
Other languages
English (en)
Inventor
Sean M Dalziel
Miroslav Rapta
Original Assignee
Theravance Biopharma R & D Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R & D Ip Llc filed Critical Theravance Biopharma R & D Ip Llc
Publication of ZA201104319B publication Critical patent/ZA201104319B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2011/04319A 2008-12-10 2011-06-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound ZA201104319B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12125408P 2008-12-10 2008-12-10
PCT/US2009/067271 WO2010068649A1 (en) 2008-12-10 2009-12-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Publications (1)

Publication Number Publication Date
ZA201104319B true ZA201104319B (en) 2012-03-28

Family

ID=42122774

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/04319A ZA201104319B (en) 2008-12-10 2011-06-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Country Status (21)

Country Link
US (4) US8101794B2 (https=)
EP (1) EP2376427B1 (https=)
JP (1) JP5650657B2 (https=)
KR (1) KR101685187B1 (https=)
CN (1) CN102245564B (https=)
AR (1) AR074592A1 (https=)
AU (1) AU2009324709B2 (https=)
BR (1) BRPI0922920A2 (https=)
CA (1) CA2745441C (https=)
CL (1) CL2011001391A1 (https=)
CO (1) CO6390054A2 (https=)
ES (1) ES2645087T3 (https=)
IL (1) IL213093A0 (https=)
MX (1) MX2011006209A (https=)
MY (1) MY179041A (https=)
NZ (1) NZ593377A (https=)
RU (1) RU2512390C2 (https=)
SG (1) SG172016A1 (https=)
TW (1) TWI449685B (https=)
WO (1) WO2010068649A1 (https=)
ZA (1) ZA201104319B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2482107C2 (ru) 2007-12-11 2013-05-20 Тереванс, Инк. Производные 3-карбоксипропил-аминотетралина и родственные соединения в качестве антагонистов mu-опиоидного рецептора
WO2009076399A2 (en) 2007-12-11 2009-06-18 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
AU2010295464B2 (en) * 2009-09-18 2015-11-26 Merck Sharp & Dohme Corp. Use of opioid receptor antagonist for gastrointestinal tract disorders
US8658691B2 (en) * 2011-09-30 2014-02-25 Theravance, Inc. Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844368B1 (en) * 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
US6498196B1 (en) * 1998-12-22 2002-12-24 Edward Roberts Compounds useful in pain management
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
RU2005134364A (ru) * 2003-04-08 2006-06-10 Проджиникс Фармасьютикалз, Инк. (Us) Комбинированное лечение запора
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
JP2010509227A (ja) 2006-11-07 2010-03-25 ネクター セラピューティックス エイエル，コーポレイション オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
EP1997493A1 (en) * 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
RU2482107C2 (ru) * 2007-12-11 2013-05-20 Тереванс, Инк. Производные 3-карбоксипропил-аминотетралина и родственные соединения в качестве антагонистов mu-опиоидного рецептора
WO2009076399A2 (en) 2007-12-11 2009-06-18 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
US8153686B2 (en) 2008-04-01 2012-04-10 Theravance, Inc. Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

Also Published As

Publication number Publication date
TWI449685B (zh) 2014-08-21
KR20110093938A (ko) 2011-08-18
AU2009324709A1 (en) 2011-06-30
BRPI0922920A2 (pt) 2019-09-24
MY179041A (en) 2020-10-26
SG172016A1 (en) 2011-07-28
CO6390054A2 (es) 2012-02-29
RU2011128393A (ru) 2013-01-20
KR101685187B1 (ko) 2016-12-09
AR074592A1 (es) 2011-01-26
EP2376427A1 (en) 2011-10-19
US8324236B2 (en) 2012-12-04
CL2011001391A1 (es) 2011-11-11
US8486958B2 (en) 2013-07-16
WO2010068649A1 (en) 2010-06-17
US8101794B2 (en) 2012-01-24
US20130345466A1 (en) 2013-12-26
CA2745441C (en) 2017-10-17
US20120088834A1 (en) 2012-04-12
CA2745441A1 (en) 2010-06-17
EP2376427B1 (en) 2017-08-02
CN102245564A (zh) 2011-11-16
MX2011006209A (es) 2011-07-12
JP5650657B2 (ja) 2015-01-07
JP2012511580A (ja) 2012-05-24
RU2512390C2 (ru) 2014-04-10
CN102245564B (zh) 2015-04-01
US20130065916A1 (en) 2013-03-14
US8969367B2 (en) 2015-03-03
TW201026646A (en) 2010-07-16
AU2009324709B2 (en) 2015-07-16
ES2645087T3 (es) 2017-12-04
US20100144881A1 (en) 2010-06-10
NZ593377A (en) 2013-07-26
IL213093A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
SI2155200T1 (sl) Kristalinična oblika kabamoil-cikloheksanskega derivata
ZA201008019B (en) A crystalline form of posaconazole
GB0819182D0 (en) Crystalline forms
GB0808840D0 (en) A compound structure
IL214126A0 (en) Crystalline insulin-conjugates
ZA201202106B (en) Substituted amide compound
IL210322A0 (en) Crystalline salts of sitagliptin
EP2339918A4 (en) PREPARATION OF A QUINOLINYLOXYDIPHENYLCYCLOPROPANEDICARBOXAMIDE
IL227812A0 (en) A compound of a derivative of cyclopentyl acrylic acid
IL216995A0 (en) Crystalline freebase forms of a biphenyl compound
SI2358676T1 (sl) Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine
ZA201105045B (en) Crystalline forms of genistein
ZA201100999B (en) Synthesis of a crystalline silicoaluminophosphate
IL216202A0 (en) PROCESS FOR THE PREPARATION OF A COMPOUND USEFUL AS AN INHIBITOR OF TAFIa
IL210777A0 (en) Crystalline forms of a pyridine derivative
ZA201104319B (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
ZA201300154B (en) Crystalline form of a 3-phenoxymethylpyrrolidine compound
GB0813347D0 (en) A set of parts
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
EP1983997A4 (en) CRYSTALLINE FORMS OF A FARNESYL DIBENZODIAZEPINONE
HU0800755D0 (en) Novel crystalline forms
IL207034A0 (en) Crystalline cinnamide compounds or salts thereof
GB0817164D0 (en) Crystalline forms
IL213288A0 (en) Crystalline forms
PL386983A1 (pl) Masa tynkarska polikrzemianowo-silikonowa